Taysha Gene Therapies Inc
(NAS:TSHA)
$
2.065
-0.085 (-3.95%)
Market Cap: 415.85 Mil
Enterprise Value: 365.67 Mil
PE Ratio: 0
PB Ratio: 7.12
GF Score: 31/100 Taysha Gene Therapies Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript
Release Date Price:
$6.34
(-2.76%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot